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Dissociation of Cerebral Blood Flow and Femoral Artery Blood
Pressure Pulsatility After Cardiac Arrest and Resuscitation in a
Rodent Model: Implications for Neurological Recovery
Christian Crouzet, PhD; Robert H. Wilson, PhD; Donald Lee, BS; Afsheen Bazrafkan, BS; Bruce J. Tromberg, PhD; Yama Akbari, MD, PhD;
Bernard Choi, PhD
Background-—Impaired neurological function affects 85% to 90% of cardiac arrest (CA) survivors. Pulsatile blood ﬂow may play an
important role in neurological recovery after CA. Cerebral blood ﬂow (CBF) pulsatility immediately, during, and after CA and
resuscitation has not been investigated. We characterized the effects of asphyxial CA on short-term (<2 hours after CA) CBF and
femoral arterial blood pressure (ABP) pulsatility and studied their relationship to cerebrovascular resistance (CVR) and short-term
neuroelectrical recovery.
Methods and Results-—Male rats underwent asphyxial CA followed by cardiopulmonary resuscitation. A multimodal platform
combining laser speckle imaging, ABP, and electroencephalography to monitor CBF, peripheral blood pressure, and brain
electrophysiology, respectively, was used. CBF and ABP pulsatility and CVR were assessed during baseline, CA, and multiple time
points after resuscitation. Neuroelectrical recovery, a surrogate for neurological outcome, was assessed using quantitative
electroencephalography 90 minutes after resuscitation. We found that CBF pulsatility differs signiﬁcantly from baseline at all
experimental time points with sustained deﬁcits during the 2 hours of postresuscitation monitoring, whereas ABP pulsatility was
relatively unaffected. Alterations in CBF pulsatility were inversely correlated with changes in CVR, but ABP pulsatility had no
association to CVR. Interestingly, despite small changes in ABP pulsatility, higher ABP pulsatility was associated with worse
neuroelectrical recovery, whereas CBF pulsatility had no association.
Conclusions-—Our results reveal, for the ﬁrst time, that CBF pulsatility and CVR are signiﬁcantly altered in the short-term
postresuscitation period after CA. Nevertheless, higher ABP pulsatility appears to be inversely associated with neuroelectrical
recovery, possibly caused by impaired cerebral autoregulation and/or more severe global cerebral ischemia. ( J Am Heart Assoc.
2020;9:e012691. DOI: 10.1161/JAHA.119.012691.)
Key Words: cardiac arrest • cerebral autoregulation • cerebral blood ﬂow • electroencephalography • laser speckle imaging •
perfusion • pulsatile
A nnually, >550 000 people in the United States experi-ence cardiac arrest (CA), and initial survival rates remain
poor (10%–30%).1 Approximately 85% to 90% of survivors have
impaired cognitive function, which leads to decreased quality
of life for survivors, increased burden on caregivers, and direct
costs of >$6 billion/year.1,2 To improve neurological recovery
and understand how the brain recovers after CA, a critical
need exists to characterize physiological processes that
impact the brain, such as cerebral blood ﬂow (CBF), arterial
blood pressure (ABP), and brain electrophysiology.
A key physiological process that has been shown to be
extremely important is pulsatile blood ﬂow because of its
impact on oxygen uptake, vascular tone, and cellular
metabolism.3 Studies have shown that pulsatile ﬂow
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(compared with nonpulsatile ﬂow) during cardiac bypass
surgery and extracorporeal membrane life support is associ-
ated with improved neurological and physiological out-
comes.4–7 Furthermore, the use of mechanically controlled
devices to induce pulsatile blood ﬂow is associated with
reduced cerebrovascular resistance (CVR) and improved
oxygen uptake during postischemic reperfusion, which can
improve neurological outcome.8 These studies show that in
the binary case of pulsatile versus nonpulsatile ﬂow, signif-
icant neurological beneﬁts occur with pulsatile ﬂow.4–8
However, aging,9–11 stroke,12 acute brain injury,13 small-
vessel disease,14 and CA15,16 all modulate pulsatile blood ﬂow
to different degrees. Results from these studies suggest
conﬂicting associations between whether increased or
decreased pulsatility results in better neurological outcome.
To better understand the relationship between pulsatility
and neurological outcome after CA, several gaps in the
knowledge base must be addressed. First, low-frequency
(<0.4-Hz) pulsatile studies have typically examined survivors
versus nonsurvivors of CA, with little analysis of neurological
function or outcome after CA.17 Second, studies of the pulsatile
waveform attributable to each heartbeat typically focus on CBF
of the middle cerebral artery15 and not cerebral microvascu-
lature or peripheral hemodynamics (eg, aorta or femoral artery).
Third, the inﬂuence of CVR on CBF and its association with the
peripheral pulsatile waveform has not been investigated.
Finally, clinical studies begin on hospital admission, followed
by measurements on subsequent days after CA, and hence do
not enable study of immediate pulsatile signal changes after
resuscitation (during ischemia-induced hyperemia and hypop-
erfusion) and their relationship to neurological outcome.
To address these gaps, we used an established, transla-
tional preclinical model of asphyxial CA (ACA) that mimics the
hospital setting.18–20 Using our novel preclinical platform, we
continuously monitored and quantiﬁed pulsatile femoral ABP
and, for the ﬁrst time, pulsatile CBF of the cerebral
microvasculature using high-speed optical imaging during
CA and resuscitation. We hypothesized that higher CBF
pulsatility would be associated with improved short-term
neuroelectrical recovery. However, we show that higher ABP
pulsatility is associated with worse short-term neuroelectrical
recovery, whereas CBF pulsatility is not associated with short-
term neuroelectrical recovery.
Materials and Methods
The data that support the ﬁndings of this study are available
from the corresponding author on reasonable request. The
ACA model and study protocol (No. 2013-3098) were
approved by the Institutional Animal Care and Use Committee
at the University of California, Irvine. Additional methods and
results can be found in Data S1.
Animal Preparation
We used our ACA model18–22 to perform experiments on 11
adult male Wistar rats (Charles River). Baseline characteristics
are shown in Table 1. Rats were calorically restricted 12 to
16 hours before onset of ACA. On the day of ACA induction,
rats were anesthetized, intubated, and connected to a
mechanical ventilator via tubing (Kent Scientiﬁc, Torrington,
CT). During surgery, isoﬂurane was maintained at 2% with a
50/50 N2/O2 mixture at 2 LPM (liters per minute). The
ventilation settings were maintained at 70 beats per minute,
with 12 to 14 cm H2O peak inspiration pressure and 3 cm
H2O peak end expiratory pressure. Animal temperature was
continuously measured with a rectal thermometer (Kent
Scientiﬁc) and maintained between 36.5°C and 37.5°C.
The intubated rat was positioned on a stereotactic frame
(Kopf Instruments, Tujunga, CA). A midline incision was
performed over the scalp, and the scalp was retracted to
expose the skull for electroencephalographic (EEG) electrode
implantation (Plastics One Inc, Roanoke, VA). Two frontal
electrodes were implanted 2 mm anterior and 2.5 mm lateral
to bregma, and a third electrode was implanted over the visual
cortex 5.5 mm posterior and 4 mm left of bregma. A reference
electrode was implanted 3 mm posterior to lambda. After
Clinical Perspective
What Is New?
• We have demonstrated that our multimodal platform, which
combines laser speckle imaging, arterial blood pressure
(BP), and electroencephalography, can monitor and quantify
BP pulsatility and cerebral blood ﬂow pulsatility in regard to
short-term neuroelectrical recovery after cardiac arrest and
resuscitation.
• Alterations in cerebral blood ﬂow pulsatility occur during the
short-term (<2 hours) postresuscitation period, yet surpris-
ingly may not be associated with short-term neuroelectrical
recovery.
• Although BP pulsatility changes little from baseline, higher
BP pulsatility after resuscitation may be associated with
worse short-term neuroelectrical recovery.
What Are the Clinical Implications?
• Our data suggest that monitoring BP pulsatility (eg, pulse
pressure) and related waveform analyses of BP within
2 hours of cardiac arrest and resuscitation may be impor-
tant to help inform the neurological recovery of patients.
• A combined effort to monitor and modify mean arterial
pressure and pulse pressure could lead to more speciﬁc BP
guidelines and the development of therapeutic interventions
that possibly target pulsatile features of BP.
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electrode implantation, a 496-mm craniectomy was created
over the right sensory and visual cortices to create a window
for optical imaging. Saline was applied periodically to ensure
the brain remained hydrated. After the craniectomy, the
femoral artery and vein were cannulated. Invasive ABP from the
femoral artery was measured continuously at 200 Hz.
Baseline arterial blood gas measurements (Abaxis, Union City,
CA) were obtained within 30 minutes before initiation of ACA.
Experimental Protocol
At experiment start time, rats were placed on 0.5% to 1.0%
isoﬂurane (balance, 100% O2). After 2 minutes, inhaled air
was changed to room air (21% O2), isoﬂurane administration
was turned off to wash out anesthesia, and neuromuscular
blockade was initiated with 1 mL of IV vecuronium (2 mg/kg),
ﬂushed with 1 mL of heparinized saline. At 5 minutes,
asphyxia was initiated by turning the ventilator off and
clamping the tubing. Rats were subjected to a period of either
5- or 7-minute asphyxia to mimic mild or moderate severity of
CA, respectively. Thirty seconds before the end of the
asphyxial period, mechanical ventilation was reinitiated at
100% O2 with respiratory rate of 75 to 85 beats per minute,
peak inspiration pressure of 17.5 to 18.5 cm H2O, and peak
end expiratory pressure of 3 cm H2O at 2.5 LPM. Epinephrine
(0.01 mg/kg) and sodium bicarbonate (1 mmol/kg), followed
by 2 mL of heparinized saline, were administered intra-
venously. Chest compressions were started at the end of the
asphyxial period until return of spontaneous circulation
(ROSC) was achieved. Arterial blood gases were obtained
10 minutes after ROSC and every 40 minutes thereafter, to
assess and modify ventilator settings as necessary.
Data Acquisition
As previously described in detail,18 we used a multimodal
approach that combined laser speckle imaging (LSI), ABP, and
electroencephalography to monitor CBF, femoral ABP, and
brain electrophysiology before, during, and after ACA and
resuscitation. Brieﬂy, LSI data were obtained using an 809-nm
laser (Ondax Inc, Monrovia, CA) as the excitation source,
and images were acquired at 60 fps (frames per second)
using a Point Grey camera with a 10-ms exposure time. To
measure ABP, systolic and diastolic blood pressures were
recorded from the femoral artery at 200 Hz. The mean
arterial pressure (MAP) was calculated at 1 Hz from the
extracted systolic and diastolic blood pressure waveforms.
EEG data acquisition was recorded from each implanted
electrode at 1526 Hz with a ﬁrst-order high-pass ﬁlter
(0.35 Hz). EEG and ABP data were collected via a Tucker
Davis Technologies (Alachua, FL) RZ5D platform and digitally
time synchronized. The LSI data were manually synchronized
to EEG and ABP data using the experiment start time
(time=0 minutes).
Initial Data Processing
LSI processing used custom-written MATLAB (The Mathworks
Inc, Natick, MA) code to process each raw speckle image and
obtain CBF data. A 595 sliding window was used to convert
each raw speckle image to a corresponding speckle contrast
(K) image using the equation K=r/<I>, where r is the SD of
the intensity and <I> is the average intensity within each
sliding window position. Each speckle contrast image was
then converted to a CBF map using a simpliﬁed speckle
imaging equation CBF=1/2TK2, where T is the exposure time
of the camera in seconds.23 A representative region of
interest was then selected within the craniectomy to obtain
an average CBF value and create time-resolved pulsatile CBF
waveforms. To create pulsatile relative CBF (rCBF) time
courses, we normalized the CBF at each time point to the
baseline CBF. The baseline CBF was deﬁned as the mean CBF
calculated over a 1-minute interval immediately before the
onset of asphyxia.
Table 1. Baseline Characteristics of Study Subjects
Characteristics 5-min ACA (n=6) 7-min ACA (n=5) P Value
Preparation time, h 6.28 (5.29–6.64) 5.23 (5.13–5.27) 0.537
Weight, g 333 (328–378) 355 (341–374) 0.937
Temperature, °C 37.0 (36.7–37.3) 37.0 (37.0–37.2) 0.944
pH 7.40 (7.40–7.40) 7.43 (7.42–7.45) 0.346
PCO2, mm Hg 39.7 (37.2–41.4) 34.8 (34.0–39.2) 0.247
PO2, mm Hg 159.5 (144.0–175.0) 139.0 (128.0–141.0) 0.247
HCO3 , mmol/L 25.4 (24.5–25.7) 25.4 (23.1–25.6) 0.662
Hemoglobin, g/dL 12.6 (11.2–13.4) 12.2 (10.9–12.9) 0.771
Data are presented as median (interquartile range). The P value was calculated with a 2-sided Wilcoxon ranked sum test. ACA indicates asphyxial cardiac arrest.
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Raw EEG data were ﬁltered using custom-written MATLAB
code. Data were detrended, and common average referencing
was performed using each electrode.24 A ﬁnite impulse
response notch ﬁlter at 60 Hz was used, followed by a ﬁnite
impulse response bandpass ﬁlter from 1 to 150 Hz. Signals
were then downsampled to 600 Hz to reduce computational
time.
Pulsatile Signal Analysis
To quantify CBF and ABP pulsatile waveform changes in
response to ACA, 2 previously published methods were
used. The ﬁrst method used the maximum value of the
power spectrum (peak power), and the second calculated
the difference between the peak and trough values (peak to
trough) of the pulsatile waveform signal25–27 (shown in
Figure 1B). CBF and ABP data from each experiment were
analyzed. Time periods during signal artifact caused by
bleeding, movement, and noise, arterial blood gas mea-
surements, and the absence of pulsatile data during the
later periods of CA were manually removed from further
analysis.
To use the peak power from the power spectrum, an
accurate measurement of heart rate is needed. Previous
articles have used LSI to quantify the heart rate and pulsatile
blood ﬂow waveform ﬂow from the skin26–28 and teeth.29
However, to the best of our knowledge, LSI has never been
used to obtain and quantify pulsatile CBF data during CA and
resuscitation. To ensure accurate CBF peak power quantiﬁ-
cation from the power spectrum, the CBF heart rate was
compared with the ABP heart rate as the gold standard. See
Results (Figure 2) for comparison.
Figure 1. Pulsatile cerebral blood ﬂow (CBF) and arterial blood pressure (ABP) dynamics after resuscitation from asphyxial cardiac arrest
(ACA). A, Relative CBF (rCBF) (green; top) and ABP (purple; bottom) time courses during a representative ACA and resuscitation experiment.
B through F, Representative 1.5-second periods of rCBF data from phases labeled in A (top). The y axis is rescaled for each ﬁgure (B through F)
to show the same CBF range. B, Baseline pulsatile CBF. C, Cardiac arrest (CA) pulsatile CBF. D, Hyperemia pulsatile CBF. E, Early hypoperfusion
pulsatile CBF. F, Late hypoperfusion pulsatile CBF. G through K, Representative 1.5 seconds of ABP data from phases labeled in A (bottom).
The y axis is rescaled for each ﬁgure (G through K) to show the same blood pressure range. G, Baseline pulsatile ABP. H, CA pulsatile ABP.
I, Hyperemia pulsatile ABP. J, Early hypoperfusion phase of pulsatile ABP. K, Late hypoperfusion phase of pulsatile ABP. CPR indicates
cardiopulmonary resuscitation.
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To obtain the heart rate and extract the peak power from
the power spectrum, the following steps were performed for
both the pulsatile CBF and ABP time courses. First, a bandpass
ﬁlter from 0.5 to 10 Hz was used to remove the DC component
and low- and high-frequency content. Next, the time-resolved
power spectrum was computed using 10-second intervals with
2 seconds of overlap. During nonasphyxial periods, the
maximum power in the 4- to 9-Hz (240–540 beats/minute,
typical rat heart rate values) frequency band was extracted
within each interval. During the asphyxial period, the maximum
power from all frequencies was extracted within each interval.
Time courses of peak power were then normalized to the
baseline peak power, which is deﬁned as the mean peak power
during a 1-minute period immediately preceding the onset of
asphyxia. The heart rate was computed by extracting the
frequency that corresponded to the peak power. The heart rate
calculated from the CBF data was compared with the heart rate
calculated from the ABP data.
To calculate the peak-to-trough time courses from the
pulsatile CBF and ABP signals, the following steps were
performed. First, a bandpass ﬁlter from 0.5 to 10 Hz was
used. Next, local peaks and troughs were determined over 1-
second intervals using the pulsatile signals for the entire time
course. A 10-second sliding average ﬁlter was applied to the
peak and trough time courses separately. The difference
between the ﬁltered peak and trough time courses was
calculated to obtain the peak-to-trough data. Time courses of
peak to trough were then normalized to the baseline peak to
Figure 2. Heart rate calculations from cerebral blood ﬂow (CBF) data agree well with those from arterial blood pressure (ABP) data during all
experimental phases. A, Time courses from each of the 11 subjects that compare ABP and CBF heart rate (HR) calculations. Data from laser
speckle imaging to measure CBF are in green, and data from peripheral ABP are in purple. B, Comparison of ABP and CBF HR calculations from
all experiments (n=11) during asphyxial (n=358; R2=0.80; left), nonasphyxial (n=4615; R2=0.93; middle), and all experimental time points
(n=4973; R2=0.94; right).
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trough, which is deﬁned as the mean peak to trough during a
1-minute period immediately preceding the onset of asphyxia
to minimize effects caused by isoﬂurane.
Cerebrovascular Resistance
Relative CVR versus time [rCVR(t)] is deﬁned as rCVR(t)=rMAP
(t)/rCBF(t),30 where rMAP is the MAP normalized by the
baseline MAP, which is deﬁned as the mean MAP calculated
over a 1-minute interval immediately before onset of asphyxia.
rCBF was calculated as follows. A 10-second sliding median
ﬁlter was applied to the pulsatile CBF time courses to remove
the pulsatile component. The ﬁltered waveform was then
normalized to the mean median-ﬁltered CBF calculated over a
1-minute interval immediately before onset of asphyxia. The
rCBF data were then downsampled to 1 Hz to match the
rMAP data, and the rCVR was calculated as the quotient of the
2 waveforms.
Electroencephalographic Information Quantity
To obtain a measurement of short-term neuroelectrical
recovery, we used a qEEG (quantitative EEG) method called
information quantity (IQ).31,32 The following steps were
performed to obtain EEG IQ as a function of time. Using a
temporal sliding window of 10 seconds with 20% overlap, a 5-
level discrete wavelet transform was applied to the ﬁltered
EEG data to extract discrete wavelet transform coefﬁcients.
One minute before the onset of asphyxia, 20 ﬁxed microstates
were calculated that encompassed the mean3 SDs of the
discrete wavelet transform coefﬁcients. A histogram of the
continuous EEG recording was created using the discrete
wavelet transform coefﬁcients with 20 microstates. The
probability distribution function was calculated, from the
histogram, and the Shannon entropy (SE) was calculated
using the equation SE ¼ P Mm¼1pdfðmÞlog2ðpdf(m)Þ. M is
the number of microstates, and pdf is the probability
distribution function from the histogram. We used this
equation within each 10-second window to calculate EEG IQ
as a function of time. The EEG IQ was then normalized to the
baseline EEG IQ, which is deﬁned as the mean EEG IQ
calculated over a 1-minute interval immediately before onset
of asphyxia. An EEG IQ of 0 indicates no brain electrical
activity, whereas an EEG IQ of 1 indicates normal brain
electrical activity.
Extracted Parameters and Statistical Analysis
To assess changes in CBF and ABP pulsatility, the peak
power and peak-to-trough data were extracted over
1-minute intervals during baseline, CA, hyperemia (10 min-
utes after ROSC), early hypoperfusion (20 minutes after
ROSC), and late hypoperfusion (60 minutes after ROSC).
These periods are labeled in Figure 1 as B through F and G
through K for the CBF and ABP data, respectively. Similarly,
rCVR was extracted during the same time intervals. To
determine the effects of asphyxial duration on peak power,
peak to trough, and rCVR, a 2-sided Wilcoxon ranked sum
test was used to compare 5- and 7-minute ACA at baseline,
CA, hyperemia, early hypoperfusion, and late hypoperfusion.
To determine the response of peak power, peak to trough,
and rCVR after ACA, a 2-sided, paired Wilcoxon signed rank
test was used to compare baseline levels with subsequent
experimental time periods. To determine the association
between pulsatility and rCVR, a Spearman ranked correla-
tion was used.
To obtain a metric of short-term neuroelectrical recovery, a
surrogate for neurological outcome, the median EEG IQ from
90 to 100 minutes after ROSC was determined. To assess the
relationship between CBF and ABP pulsatility to short-term
neuroelectrical recovery, a Spearman ranked correlation was
used.
Results
Arterial blood gas measurements taken 10, 50, and 90
minutes after ROSC are shown in Table 2. There is no
signiﬁcant difference between 5- and 7-minute ACA for pH,
PCO2, PO2, HCO

3 , and hemoglobin at all time points (P>0.05).
After Resuscitation From ACA, CBF and Femoral
Artery Pulsatility Characteristics Vary
Considerably
Figure 1A shows representative time courses of CBF (top)
and ABP (bottom) after an ACA and resuscitation experi-
ment. ABP decreases and CBF increases during the baseline
period (0–5 minutes). We speculate that the administration
of vecuronium causes relaxation of muscles (ie, intercostal
and limb muscles) that can lead to peripheral pooling of
blood that results in a decrease in ABP, whereas arousal
and brain activation from washout of isoﬂurane in our
paradigm may cause an increase in rCBF, despite isoﬂurane
being known to increase CBF. Figure 1B through 1F shows
representative 1.5-second periods of CBF data during
speciﬁc phases labeled in Figure 1A (top). The y axis of
Figure 1B through 1F is rescaled to keep the same CBF
range in each subﬁgure. Figure 1B shows baseline pulsatile
CBF waveform with an example of the peak and trough
labeled. Figure 1C shows CBF pulsatility during CA with low
amplitude and overall low ﬂow. Figure 1D shows CBF
pulsatility during hyperemia. Compared with baseline, the
CBF waveform in this phase is higher in amplitude and
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consists of sharper features. Figure 1E shows CBF pulsatil-
ity during early hypoperfusion. The CBF pulsatility has a
lower amplitude than during both hyperemia and baseline,
with overall lower ﬂow. Figure 1F shows CBF pulsatility
during late hypoperfusion. The CBF pulsatility has a lower
amplitude than during both hyperemia and baseline, with
overall lower ﬂow. During baseline, hyperemia, and early
hypoperfusion, respiratory variations are observed as a low-
frequency oscillation in the CBF data that is not observed
during CA and is difﬁcult to visualize during late hypoper-
fusion.
Figure 1G through 1K shows representative 1.5-second
periods of ABP data during the same phases labeled in
Figure 1A (bottom). The y axis of Figure 1G through 1K is
rescaled to keep the same blood pressure range in each
subﬁgure. Figure 1G shows the pulsatile ABP waveform
during baseline. Figure 1H shows the pulsatile ABP during
CA, with a nearly featureless waveform. Figure 1I shows ABP
pulsatility during hyperemia, with a return in pulsatility and a
slightly higher amplitude than during baseline. Figure 1J
shows ABP pulsatility during early hypoperfusion. Unlike the
decreased CBF pulsatility during early hypoperfusion, the ABP
pulsatility is near baseline levels. Figure 1K shows ABP
pulsatility during late hypoperfusion, with similar pulsatility to
early hypoperfusion. During baseline, hyperemia, early hypop-
erfusion, and late hypoperfusion, respiratory variations are
observed as a slow frequency oscillation in the ABP data that
is not observed during CA.
LSI Enables Accurate Quantiﬁcation of Heart Rate
Measured From the Rodent Brain
To determine if LSI is able to quantitatively resolve CBF
heart rate changes, heart rate calculations measured from
LSI data were compared with the ABP heart rate calculations
as the gold standard. Figure 2A shows time courses of heart
rate calculations measured from each experiment using CBF
data (green) and ABP data (purple). The data collectively
show excellent agreement across all experiments (n=11).
Figure 2B quantiﬁes the linear correlation between the heart
rate calculated using all CBF and ABP data. The linear
correlation was examined in 3 periods: (1) only asphyxial
time points (left), (2) only nonasphyxial time points (middle),
and (3) combined asphyxial and nonasphyxial time points
(right). Using only asphyxial time points (n=358), the
R2=0.80; using only nonasphyxial time points (n=4615),
the R2=0.93; and using all experimental time points
(n=4973), the R2=0.94.
Table 2. Arterial Blood Gas Characteristics After ROSC
Characteristics 5-min ACA (n=6) 7-min ACA (n=5) P Value
10 min after ROSC
pH 7.28 (7.25–7.29) 7.29 (7.27–7.30) 0.537
PCO2, mm Hg 50.4 (49.4–58.2) 38.0 (36.7–44.7) 0.177
PO2, mm Hg 136.0 (83.5–221.5) 237.0 (146.0–250.0) 0.537
HCO3 , mmol/L 23.3 (22.3–25.6) 18.4 (18.0–20.5) 0.082
Hemoglobin, g/dL 10.5 (9.0–12.3) 10.9 (10.5–11.6) 0.792
50 min after ROSC
pH 7.32 (7.26–7.36) 7.42 (7.37–7.43) 0.329
PCO2, mm Hg 51.6 (44.8–66.2) 38.6 (33.3–39.3) 0.177
PO2, mm Hg 282.5 (137.3–360.3) 382.0 (341.0–385.0) 0.329
HCO3 , mmol/L 27.1 (25.7–31.0) 23.0 (22.5–26.0) 0.195
Hemoglobin, g/dL 11.8 (10.8–12.7) 10.9 (10.9–11.2) 0.758
90 min after ROSC
pH 7.44 (7.39–7.48) 7.23 (7.18–7.27) 0.052
PCO2, mm Hg 39.0 (33.8–46.0) 60.3 (59.8–64.6) 0.177
PO2, mm Hg 324.0 (190.0–458.8) 133.0 (117.0–319.0) 0.126
HCO3 , mmol/L 28.8 (24.4–29.4) 25.1 (24.8–25.8) 0.537
Hemoglobin, g/dL 10.9 (9.3–11.7) 11.2 (10.2–11.9) 0.740
Data are presented as median (interquartile range). The P value was calculated with a 2-sided Wilcoxon ranked sum test. ACA indicates asphyxial cardiac arrest; ROSC, return of
spontaneous circulation.
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CBF Pulsatility Dynamically Changes From
Baseline, Whereas ABP Pulsatility Remains Fairly
Stable
After pooling the 5- and 7-minute ACA, there was no
signiﬁcant difference between CBF and ABP pulsatility during
hyperemia (peak to trough: P=0.15; peak power: P=0.12), but
there were signiﬁcant deﬁcits in CBF pulsatility during early
hypoperfusion (peak to trough: P=0.003; peak power:
P<0.001) and late hypoperfusion (peak to trough: P<0.001;
peak power: P<0.001) in comparison to ABP pulsatility
metrics (n=11) (Figure 3).
We then compared baseline CBF and ABP pulsatility
metrics with their respective metrics during CA, hyperemia,
early hypoperfusion, and late hypoperfusion (n=11). CBF
pulsatility during CA was signiﬁcantly less than baseline CBF
pulsatility (peak to trough: P<0.001; peak power: P<0.001).
On the other hand, CBF pulsatility during hyperemia was
signiﬁcantly higher than CBF pulsatility at baseline (peak to
trough: P=0.02; peak power: P=0.03). However, CBF pulsatil-
ity during early hypoperfusion (peak to trough: P=0.003; peak
power: P<0.001) and late hypoperfusion (peak to trough:
P<0.001; peak power: P<0.001) had signiﬁcant deﬁcits in
comparison to baseline CBF pulsatility.
Meanwhile, CA ABP pulsatility was signiﬁcantly less than
baseline ABP pulsatility (peak to trough: P<0.001; peak
power: P<0.001). ABP pulsatility only showed deﬁcits in peak
power (not peak to trough) during early hypoperfusion (peak
power: P=0.01) compared with baseline ABP pulsatility.
During hyperemia and late hypoperfusion, ABP pulsatility
was not signiﬁcantly different from baseline ABP
pulsatility (n=11).
We also tested if CBF pulsatility (normalized peak to
trough) followed overall CBF changes, during hyperemia, early
hypoperfusion, and late hypoperfusion (n=11). There was a
strong signiﬁcant positive correlation during hyperemia
(R=0.86; P=0.001). However, there was no signiﬁcant corre-
lation during early (R=0.32; P=0.34) and late hypoperfusion
(R=0.37; P=0.26) (Figure S1).
Longer Asphyxial Duration Leads to Higher ABP
Pulsatility Only During the Late Hypoperfusion
Phase, But Does Not Signiﬁcantly Inﬂuence
Deﬁcits in CBF Pulsatility
To assess the effects of asphyxial duration on CBF and ABP
pulsatility, 5-minute (n=6) and 7-minute (n=5) ACA values
were compared during CA, hyperemia, early hypoperfusion,
and late hypoperfusion. There were no signiﬁcant differences
between either the normalized peak power and peak-to-
trough CBF pulsatility metrics for 5- and 7-minute ACA
experiments during each experiment phase (P>0.05)
(Figure 4A and 4B). However, during hyperemia, there was
a nonsigniﬁcant trend toward increased CBF pulsatility for
7-minute ACA experiments. There was no signiﬁcant differ-
ence between either the normalized peak power and peak-
to-trough ABP pulsatility metrics for 5- and 7-minute ACA
experiments during CA, hyperemia, and early hypoperfusion
(P>0.05) (Figure 4C and 4D). Similar to CBF pulsatility,
during hyperemia, there was a nonsigniﬁcant trend toward
increased ABP pulsatility for 7-minute ACA experiments.
However, during late hypoperfusion, 7-minute ACA experi-
ments had signiﬁcantly more ABP pulsatility than 5-minute
ACA experiments, using both the normalized peak power
Figure 3. Resuscitation after asphyxial cardiac arrest (ACA) leads to deﬁcits in cerebral blood ﬂow (CBF)
pulsatility, whereas arterial blood pressure (ABP) pulsatility minimally changes. Combined 5- and 7-minute
ACA comparison between CBF (green, circle) pulsatility and ABP (purple, square) pulsatility (n=11) using
normalized peak-to-trough metric (A) and normalized peak power metric (B). Experimental phases are
baseline (B), cardiac arrest (CA), hyperemia (H), early hypoperfusion (EH), and late hypoperfusion (LH).
*P<0.05, **P<0.01, and ***P<0.001.
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(P=0.03) and normalized peak-to-trough (P=0.03) pulsatility
metrics (Figure 4C and 4D).
CVR Is Correlated to CBF Pulsatility, But Not ABP
Pulsatility
Figure 5A illustrates a representative experimental rCVR time
course. Analyses for rCVR pooled 5- and 7-minute ACA
(n=11). Figure 5B demonstrates that rCVR increases signif-
icantly during CA (P<0.001), early hypoperfusion (P=0.002),
and late hypoperfusion (P<0.001) in comparison to baseline
rCVR (n=11). However, rCVR during hyperemia remains
similar to baseline rCVR. Interestingly, there was a signiﬁcant
negative correlation between CBF pulsatility and rCVR during
hyperemia (R=0.68; P=0.025) and late hypoperfusion
(R=0.78; P=0.007). There was also a modest trend
(nonsigniﬁcant) toward a negative correlation between CBF
pulsatility and rCVR, during early hypoperfusion (R=0.42;
P=0.20). In contrast, there was no signiﬁcant correlation
between ABP pulsatility and rCVR during hyperemia (R=0.04;
P=0.92), early hypoperfusion (R=0.34; P=0.31), and late
hypoperfusion (R=0.16; P=0.63). Interestingly, when rCVR and
overall CBF were compared, there was no signiﬁcant associ-
ation during hyperemia (R=0.52; P=0.107), early hypoper-
fusion (R=0.35; P=0.286), and late hypoperfusion
(R=0.58; P=0.066) (Figure S2). Nevertheless, there was a
trend toward signiﬁcance during late hypoperfusion.
Higher ABP Pulsatility, But Not CBF Pulsatility, Is
Associated With Worse Short-Term
Neuroelectrical Recovery
Figure 6A illustrates a representative experimental EEG IQ
time course. We ﬁrst analyzed whether overall CBF and MAP
were correlated to short-term neuroelectrical recovery (data
not shown). Because of excessive bleeding that corrupted EEG
signal acquisition, data from one subject were removed from
further consideration. Analyses pooled 5- and 7-minute ACA
(n=10). There was no signiﬁcant correlation between overall
MAP and EEG IQ 90 minutes after ROSC (a surrogate for
Figure 4. Longer asphyxial duration leads to higher arterial blood pressure (ABP) pulsatility, but does not
signiﬁcantly inﬂuence deﬁcits in cerebral blood ﬂow (CBF) pulsatility. A and B, Two methods to calculate
CBF pulsatility (normalized peak to trough and peak power) demonstrate that there is no signiﬁcant
difference in CBF pulsatility between 5-minute (n=6) and 7-minute (n=5) asphyxial cardiac arrest (ACA)
experiments during cardiac arrest (CA), hyperemia (H), early hypoperfusion (EH), and late hypoperfusion
(LH). C and D, Two methods to calculate ABP pulsatility (normalized peak to trough and peak power)
demonstrate that there is no signiﬁcant difference between 5-minute (n=6) and 7-minute (n=5) ACA
experiments during CA, H, and EH (P>0.05). During LH, 7-minute ACA experiments have signiﬁcantly
greater pulsatility than 5-minute experiments (P=0.03). Experimental phases are baseline (B), CA, H, EH,
and LH. (*P<0.05).
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short-term neurological recovery)31 during hyperemia
(R=0.53; P=0.12), early hypoperfusion (R=0.31; P=0.39),
or late hypoperfusion (R=0.32; P=0.37). Similarly, there was
no signiﬁcant correlation between overall CBF and EEG IQ
90 minutes after ROSC during hyperemia (R=0.2; P=0.58),
early hypoperfusion (R=0.21; P=0.56), or late hypoperfusion
(R=0.13; P=0.73).
We then investigated the relationship between pulsatility
metrics and EEG IQ 90 minutes after ROSC. As seen in
Figure 6B through 6D, there was no signiﬁcant trend between
EEG IQ 90 minutes after ROSC and CBF peak to trough during
hyperemia (R=0.20; P=0.58), early hypoperfusion (R=0.21;
P=0.56), and late hypoperfusion (R=0.13; P=0.73). There was
no signiﬁcant trend between EEG IQ 90 minutes after ROSC
Figure 5. Relative cerebrovascular resistance (rCVR) increases after resuscitation and is inversely correlated to cerebral blood ﬂow (CBF)
pulsatility but not arterial blood pressure (ABP) pulsatility. A, Representative experiment illustrating temporal changes in rCVR. B, Combined 5-
and 7-minute asphyxial cardiac arrest (ACA) shows rCVR is signiﬁcantly elevated during cardiac arrest (CA) (P<0.001), early hypoperfusion (EH)
(P=0.002), and late hypoperfusion (LH) (P<0.001), whereas rCVR remains at near baseline (B) levels during hyperemia (H) (P=0.17) (n=11).
Experimental phases are B, CA, H, EH, and LH. C through E, Combined 5- and 7-minute ACA comparison of CBF normalized peak-to-trough data
and rCVR during H, EH, and LH (n=11). C, Comparison of CBF pulsatility and normalized rCVR during H (R=0.68; P=0.025). D, Comparison of
CBF pulsatility and normalized rCVR during EH (R=0.42; P=0.20). E, Comparison of CBF pulsatility and normalized rCVR during LH (R=0.78;
P=0.007). F through H, Combined 5- and 7-minute ACA comparison of ABP normalized peak-to-trough data and normalized rCVR during H, EH,
and LH (n=11). F, Comparison of ABP pulsatility and normalized rCVR during H (R=0.04; P=0.92). G, Comparison of ABP pulsatility and
normalized rCVR during EH (R=0.34; P=0.31). H, Comparison of ABP pulsatility and normalized rCVR during LH (R=0.16; P=0.63). (*P<0.05,
**P<0.01, ***P<0.001).
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and ABP peak to trough during hyperemia (R=0.32; P=0.37)
(Figure 6E) and early hypoperfusion (R=0.52; P=0.13)
(Figure 6F). However, there was a signiﬁcant negative trend
comparing EEG IQ 90 minutes after ROSC and ABP peak to
trough during late hypoperfusion (R=0.76; P=0.016) (Fig-
ure 6G).
Discussion
Pulsatile blood ﬂow is critical in oxygen uptake, vascular tone,
cellular metabolism,3 and the clearance of metabolites
through the glymphatics.33 However, measuring pulsatility
remains challenging, especially in the brain. Transcranial
Doppler approaches probe the middle cerebral artery and
measure CBF pulsatility in humans, but lack information about
the cerebral microvasculature, which plays a vital role in
oxygen metabolism.34 Another essential mechanism for brain
function, health, and homeostasis is cerebral autoregulation,
which is the ability of the brain to maintain CBF when
peripheral blood pressure changes. One way to assess
cerebral autoregulation is measuring CVR. Simultaneously
measuring CBF pulsatility, ABP pulsatility, and CVR has been
challenging because of a lack of multimodal platforms. These
measurements have been equally difﬁcult in preclinical
models because of a lack of high-speed tools that are needed
for the increased heart rate in animal models. However, these
measurements in a controlled, preclinical setting are essential
to understand the complex physiological characteristics in
Figure 6. Worse short-term neuroelectrical recovery is associated with higher arterial blood pressure (ABP) pulsatility, whereas changes in
cerebral blood ﬂow (CBF) pulsatility are not associated with short-term neuroelectrical recovery. A, Representative experiment that shows
temporal changes in electroencephalographic (EEG) information quantity (IQ). B through D, Combined 5- and 7-minute asphyxial cardiac arrest
(ACA) comparisons of CBF normalized peak-to-trough data during hyperemia (H), early hypoperfusion (EH), and late hypoperfusion (LH) to EEG IQ
90 minutes after return of spontaneous circulation (ROSC) (n=10). Experimental phases are baseline, cardiac arrest, H, EH, and LH. B,
Comparison of CBF pulsatility during H and EEG IQ 90 minutes after ROSC (R=0.20; P=0.58). C, Comparison of CBF pulsatility during EH and
EEG IQ 90 minutes after ROSC (R=0.21; P=0.56). D, Comparison of CBF pulsatility during LH and EEG IQ 90 minutes after ROSC (R=0.13;
P=0.73). E through G, Combined 5- and 7-minute ACA comparisons of ABP normalized peak-to-trough data during H, EH, and LH to EEG IQ
90 minutes after ROSC (n=10). E, Comparison of ABP pulsatility during H and EEG IQ 90 minutes after ROSC (R=0.32; P=0.37). F, Comparison
of ABP pulsatility during EH and EEG IQ 90 minutes after ROSC (R=0.52; P=0.13). G, Comparison of ABP pulsatility during LH and EEG IQ
90 minutes after ROSC (R=0.76; P=0.016).
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brain disease and trauma, which drive the need for the
development and use of high-speed tools.
One area of interest where there is a critical need to
measure high-speed changes is CA and resuscitation. We
previously published on the relationship between overall CBF
and ABP, and how we can use this information to predict the
resumption of EEG activity after resuscitation.18 In this study,
we improved on our platform to show, for the ﬁrst time,
simultaneous measurement of CBF pulsatility, ABP pulsatility,
and CVR and relate these changes to short-term neuroelec-
trical recovery in a preclinical model of CA and resuscitation.
Our results reveal that the response of CBF and ABP pulsatility
to ACA and resuscitation differs (Figures 3 and 4); and that
CBF pulsatility demonstrates persistent deﬁcits concomitant
with increases in rCVR (Figure 5) that appear independent of
overall CBF changes (Figures S1 and S2) within 2 hours after
resuscitation. Interestingly, these deﬁcits in CBF pulsatility do
not appear to be associated with short-term neuroelectrical
recovery, whereas higher ABP pulsatility is associated with
worse short-term neuroelectrical recovery (Figure 6).
Poor neurological recovery remains a common occurrence
for patients with acute brain injury. CA35–37 and non-CA14,38–
40 studies have quantiﬁed CBF and ABP pulsatility attributable
to each heartbeat. On the basis of the collective published
results, controversy exists about whether higher or lower
pulsatility is related to better neurological outcome. For
example, the following results from CA studies that examined
the middle cerebral artery have reported the following: (1)
lower pulsatility index (PI) is associated with good outcome,37
(2) there is no relationship between PI and survivability up to
72 hours after admission to the intensive care unit,36 and (3)
good neurological outcome had higher PIs in the initial
48 hours after admission to the intensive care unit.35 Results
by van den Brule et al15 and Lemiale et al36 suggest that
post-ROSC changes in pulsatile CBF are caused by increased
level of vasoconstrictors and cerebral arterial resistance, but
that mortality depends on the presence of luxury perfusion.
However, these 2 CA studies do not comment on how CBF
pulsatility impacts neurological outcome. Non-CA studies
showed that patients with higher pulse pressure, which is
analogous to ABP peak to trough measured in this study, have
the following: (1) increased likelihood to develop restenosis
after percutaneous transluminal coronary angioplasty,38 (2)
higher prevalence of subcortical infarcts and worse cognitive
function in the aging population,39 (3) more severe forms of
leukoaraiosis,14 and (4) higher incidence of stroke.40 Mitchell
et al39 and Webb et al14 reported that increased stiffening of
the aorta is associated with reduced wave reﬂection and,
therefore, transmission of excessive pulsatility into the brain,
which can lead to structural brain damage of the microvas-
culature and impaired cognitive function.14,39 Our data
support this result, as we showed that higher ABP pulsatility
is associated with worse short-term neuroelectrical recovery
(Figure 6G). A key difference is that the ﬁndings in previous
studies were caused by long-term increases in pulsatility,
which may lead to cerebral microvascular damage. The results
presented in our study are related to short-term changes in
ABP pulsatility that occur over the course of <2 hours after
global cerebral ischemia.
One potential reason that short-term changes in increased
ABP pulsatility may lead to more cerebral microvascular
damage is impaired cerebral autoregulation. After CA, cere-
bral autoregulation is impaired41,42 and overall CBF dimin-
ished, but ABP recovers to baseline levels.18,32,43,44 Several
studies reported that higher variability in low-frequency CBF
and MAP signals 72 hours after admission to the intensive
care unit was associated with increased chance of survival.17
These studies suggested that decreased low-frequency vari-
ability and higher mortality are associated with impaired
myogenic response and autonomic regulation.17 However,
previous studies did not compare cerebral autoregulation
measures, such as CVR, to CBF and ABP pulsatility. Our
imaging approach provides the requisite capabilities to
monitor these hyperdynamic changes in relation to short-
term neuroelectrical recovery. Our data suggest that CVR is
elevated during the hypoperfusion phases after resuscitation
(Figure 5B), and is associated with CBF pulsatility but not ABP
pulsatility (Figure 5C through 5H). These results suggest that
CVR may be more dependent on pulsatile cerebral hemody-
namics than pulsatile peripheral hemodynamics. However, in
cases of impaired cerebral autoregulation, excessive periph-
eral pulsatility and overall hemodynamics may lead to damage
of cerebral microvasculature. We did not observe a signiﬁcant
difference between CVR for 5- and 7-minute ACA experiments
during any of the time points (P>0.05). However, during late
hypoperfusion, subjects experiencing 7-minute ACA had
signiﬁcantly more ABP pulsatility than those experiencing 5-
minute ACA (P=0.03). Thus, we postulate that more severe CA
affects cerebral autoregulation and increases ABP pulsatility.
Hence, the brain is unable to modulate the increased ABP
pulsatility, which may lead to increased reperfusion-mediated
cerebral microvascular damage. On the basis of the demon-
strated association between CVR and CBF pulsatility (Fig-
ure 5C through 5E), we hypothesize that a normal CVR, or
less impaired cerebral autoregulation, enables the brain to
minimize the potential harm that an elevated pulsatile ABP
may cause the cerebral microvasculature, which in turn may
lead to better neurological recovery.
However, another potential explanation of the association
between higher ABP pulsatility and worse short-term neuro-
electrical recovery could be that the subjects with higher ABP
pulsatility experienced more severe ACA (Figure 4). The more
severe ACA and increase in ABP pulsatility may lead not only
to more damage to the cerebral microvasculature, but also to
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the cardiac and systemic microvasculature. Furthermore, the
increase in ABP pulsatility may also be a compensatory
mechanism after more severe global ischemia to potentially
offset the observed deﬁcits in CBF pulsatility (Figure 3). To
address these gaps, mechanistic studies are needed to
determine causality between severity of ACA, CBF pulsatility,
and ABP pulsatility and how these affect the brain and
neurological outcome. A better understanding of how cere-
bral, cardiac, and systemic vasculature is affected after CA
pulsatility may also help target future development and use of
therapeutic agents after CA.
Hemodynamic targets for patients experiencing CA rely on
targeting systolic blood pressure and MAP of >90 and
65 mm Hg, respectively.45 These targets typically do not
consider ABP pulsatility. Studies have shown that exceeding a
threshold of MAP is associated with good neurological
recovery46,47; however, these studies did not examine the
relationship between pulse pressure and elevated MAP on
neurological outcome. Our results, which show that higher
ABP pulsatility is associated with worse short-term neuro-
electrical recovery parameters, suggest that monitoring acute
ABP pulsatility may help inform neurological recovery after
CA. We postulate that a combined effort to monitor MAP and
pulse pressure could potentially lead to discoveries that can
allow for minimization of cerebral microvascular damage and
possibly improve good neurological outcome after CA.
Epinephrine administration is the standard of clinical practice
during cardiopulmonary resuscitation.48 However, recent
studies demonstrated that epinephrine alone can lead to
decreased survivability and worse neurological outcome than
when epinephrine is combined with vasopressin or sodium
nitroprusside.49–54 It is not clear how these drugs affect
pulsatility of the peripheral arteries versus cerebral arteries.
Future studies that determine how these drugs affect
pulsatility, and therapeutic modulation of pulsatility during
the short-term period after CA (within 2 hours), may be
critical to achieving an overall improvement in neurological
outcome.
Limitations
Although the ﬁndings of this study warrant further investiga-
tions, there are several limitations. First, global regions of
interest within the craniectomy were chosen to calculate CBF
data, and therefore we did not distinguish between arteriolar
and venular pulsatility, which has recently been shown with
LSI.25 In separate analyses of our data, regions of interest that
were taken exclusively from arterioles were analyzed. Our
data resulted in poor signal/noise ratio of the pulsatile
waveform, which did not enable the use of the quantiﬁable
metrics presented in this study. Furthermore, another limita-
tion of using LSI to quantify pulsatility is that it cannot
calculate PI, a well-accepted measure of pulsatility. Absolute
velocity is needed to calculate PI; however, the LSI signal is
more of a perfusion measurement. Also, although the data
analyses presented herein produce statistical signiﬁcance and
trends, the power of these ﬁndings is limited because of the
small sample size and complexity of experiments. Speciﬁcally,
there appears to be a trend toward decreased CBF pulsatility
and longer duration of ACA, but we did not see statistically
signiﬁcant differences (Figure 4A and 4B). Furthermore, these
experiments used a craniectomy, which may affect pulsatile
CBF changes because of differences in intracranial pressure
and brain pulsations. A chronic cranial window may mitigate
such effects. To address this limitation, we performed 2 ACA
experiments using a chronic cranial window procedure55 that
showed similar changes in CBF pulsatility compared with the
open craniectomy procedure (Figure S3). Moreover, we used
isoﬂurane to induce anesthesia, which may impact CBF and
ABP pulsatility. Isoﬂurane was turned off 3 minutes before
onset of asphyxia to minimize isoﬂurane effects on pulsatility.
In addition, the correlations in this study combined the 5- and
7-minute ACA groups because of the small sample size.
Moreover, because we used young, healthy animals, these
data should be reinvestigated in aged animals with heart
disease and decreased cardiac function to better mimic the
human population at highest risk of CA. It may be possible
that ABP pulsatility and compensatory cardiac function after
CA are highly different in the diseased state. Thus, future work
should use larger sample sizes in varying severities of ACA
using young and aged animals and use linear regression
models. Our metric of neurological outcome (EEG IQ),
although it is an objective end point that has been previously
validated,31 is not based on cognitive,56 behavioral,21 or
histopathological outcomes.37,57 Finally, the results in this
study only measured acute pulsatility changes. Use of a
wearable imaging device27,55,58 over a chronic cranial window
will enable longer-term monitoring of CBF pulsatility.
Conclusions
We used our translational preclinical model of ACA and a
multimodal measurement platform to demonstrate that CBF
pulsatility dynamically changes after resuscitation, whereas
ABP pulsatility changes little. rCVR appears to be associated
to changes in CBF pulsatility, but not ABP pulsatility. We found
that our observed changes in CBF pulsatility are not
correlated with short-term neuroelectrical recovery, whereas
higher ABP pulsatility is associated with worse short-term
neuroelectrical recovery. We postulate that impaired cerebral
autoregulation after CA may contribute to higher ABP
pulsatility, leading to worse short-term neuroelectrical recov-
ery. However, this may also be attributable to higher ABP
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pulsatility being associated with more severe ACA. Clinical
translation of these ﬁndings has the potential to inform us on
the development of novel interventions that modulate cere-
bral autoregulation and ABP pulsatility within the ﬁrst 2 hours
after ROSC, which could potentially improve neurological
outcome for CA survivors.
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Data S1. 
 
Supplemental Methods 
To assess if the relationship between CBF pulsatility and rCVR is driven by overall CBF 
we compared rCBF to CBF pulsatility and rCVR, respectively. rCBF was extracted over a one-
minute interval during hyperemia (~10min post-ROSC), early hypoperfusion (~20min post-
ROSC), and late hypoperfusion (~60min post-ROSC). To determine the association between 
overall CBF and CBF pulsatility, a Spearman ranked correlation was used during each phase. 
To determine the association between overall CBF and rCVR, a Spearman ranked correlation 
was used during each phase.  
 
We performed chronic cranial window experiments to assess if an open or closed 
cerebral system affects CBF pulsatility. The following procedures were performed. First, the 
skull was removed, similar to our open craniectomy experiments; second, the dura was 
removed; third, agarose was placed over the exposed brain; lastly, a coverslip was placed on 
top and glued to the skull. After surgery, rats were given approximately three weeks before 
induction of ACA. 5min ACA was used for chronic cranial window experiments. We compared 
CBF pulsatility from the open craniectomy experiments to the chronic cranial window 
preparation. 
 
Supplemental Results 
Our data shows that rCBF and CBF pulsatility were significantly correlated during 
hyperemia (R = 0.86, p = 0.001) (Figure S1A). However, there was no significant correlation 
during early (R = 0.32, p = 0.341) (Figure S1B) and late hypoperfusion (R = 0.37, p = 0.261) 
(Figure S1C). 
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There was no significant association between rCVR and rCBF during hyperemia (R = -
0.52, p = 0.107) (Figure S2A), early (R = -0.35, p = 0.286) (Figure S2B) and late hypoperfusion 
(R = -0.58, p = 0.066) (Figure S2C) Although there was a trend towards significance during late 
hypoperfusion. 
Our data show good agreement between the open craniectomy and chronic cranial 
window preparations (Figure S3). Furthermore, CBF pulsatility from chronic cranial window 
preparation is on the lower end of the pulsatility values measured with the open craniectomy 
preparations. This observation suggests that brain pulsations may potentially be causing a mild 
artifact in our open craniectomy data. Thus, the open craniectomy experiments may show an 
artificial increase in CBF pulsatility due to brain pulsations. Nevertheless, this control experiment 
supports overall corroborating trends between the open and closed craniectomy models during 
the different phases of cardiac arrest and post-cardiac arrest time points and supports our main 
conclusions. 
  
D
ow
nloaded from
 http://ahajournals.org by on January 21, 2020
Figure S1. Cerebral blood flow (CBF) pulsatility and overall CBF are associated during 
hyperemia, but not early and late hypoperfusion. 
 
 
(A) Comparison of CBF pulsatility and overall CBF during hyperemia (R = 0.86, p = 0.001). (B) 
Comparison of CBF pulsatility and overall CBF during early hypoperfusion (R = 0.32, p = 0.341). 
(C) Comparison of CBF pulsatility and overall CBF during late hypoperfusion (R = 0.37, p = 
0.261). 
  
D
ow
nloaded from
 http://ahajournals.org by on January 21, 2020
Figure S2. Overall cerebral blood flow (CBF) and relative cerebrovascular resistance 
(rCVR) are not significantly associated post-cardiac arrest (CA). 
 
 
 
(A) Comparison of overall CBF and normalized rCVR during hyperemia (R = -0.52, p = 0.107). 
(B) Comparison of overall CBF and normalized rCVR during early hypoperfusion (R = -0.35, p = 
0.286). (C) Comparison of overall CBF and normalized rCVR during late hypoperfusion (R = -
0.58, p = 0.066). 
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Figure S3. Chronic cranial window cerebral blood flow (CBF) pulsatility agrees with open 
craniectomy CBF pulsatility. 
 
 
 
The open craniectomy data (n=11) is shown in green and the chronic cranial window data (n=2) 
is shown in red. Experimental phases are baseline (B), cardiac arrest (CA), hyperemia (H), early 
hypoperfusion (EH), and late hypoperfusion (LH). 
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